[mo_oauth_login]
Summary report
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Date of report 26.03.2025
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
11558952 -
Registered
Founded in
15.12.2008
Fixed capital
9,959 €
keywords
- ärinõustamine
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Scores and ratings
Reputation score
550
What is Reputation score?
Credit Score
Neutral
0.06
Credit score today
Neutral
0.06
2011
year
Open the reports you want to print
Employees and salaries
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Number of employees and estimated average salaries?
| 2024 I | 2024 II | 2024 III | 2024 IV | |
| Number of employees | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
| 2023 I | ...... | ...... | ...... | ...... |
| 2022 IV | ...... | ...... | ...... | ...... |
| 2022 III | ...... | ...... | ...... | ...... |
| 2022 II | ...... | ...... | ...... | ...... |
| 2022 I | ...... | ...... | ...... | ...... |
| 2021 IV | ...... | ...... | ...... | ...... |
| 2021 III | ...... | ...... | ...... | ...... |
| 2021 II | ...... | ...... | ...... | ...... |
| 2021 I | ...... | ...... | ...... | ...... |
| 2020 IV | ...... | ...... | ...... | ...... |
| 2020 III | ...... | ...... | ...... | ...... |
| 2020 II | ...... | ...... | ...... | ...... |
| 2020 I | ...... | ...... | ...... | ...... |
| 2019 IV | ...... | ...... | ...... | ...... |
| 2019 III | ...... | ...... | ...... | ...... |
| 2019 II | ...... | ...... | ...... | ...... |
| 2019 I | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Decision-makers?
Former decision-makers
Relations:
1
Turnover:
Employees:
2
Ludovit Slučiak
★★★★
......
Credit Score: Trustworthy
Reputation score: 550
Date of birth: ......
Active relations 1
1 follower
Relations:
1
Turnover:
Employees:
2
Rndr Elena Slučiakova
★★★★
......
Credit Score: Trustworthy
Reputation score: 550
Date of birth: ......
Active relations 1
1 follower
Relations:
1
Turnover:
Employees:
2
Janne Kärsten
★★★★
......
Credit Score: Trustworthy
Reputation score: 550
Date of birth: ......
Active relations 1
1 follower
*
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Former decision-makers?
Relations:
8
Turnover 2024:
172 840 €
Employees:
Oliver Pullisaar
★★★★
......
Credit Score: Trustworthy
Reputation score: 1390
Date of birth: ......
Active relations 8
1 follower
Relations:
Turnover:
Employees:
Andis Bušs
★★★★
......
Credit Score: None
Reputation score: None
Date of birth: ......
Active relations 0
0 followers
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
History of right of representation?
Field
Professional Activities
Business age
16y
Beneficial country:
The United Nations
Janne Kärsten
... - ...
Ludovit Slučiak
... - ...
Rndr Elena Slučiakova
... - ...
Andis Bušs
... - ...
Oliver Pullisaar
... - ...
2008
2010
2013
2015
2018
2020
2023
2025
2008
2010
2011
2013
2014
2016
2017
2019
2020
2022
2023
2025
Finances and assets
UNIMED PHARMA SPOL.S R.O. EESTI ...
Goodwill| EUR | 2023 | 2024 | 2025 | Trend |
| Goodwill | ...... | ...... | ...... | |
| Goodwill | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Taxes paid and estimated average salaries| 2021 | 2022 | 2023 | 2024 | |
| National taxes | ...... | ...... | ...... | ...... |
| Labor taxes | ...... | ...... | ...... | ...... |
| Average gross salary | ...... | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2024 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2022 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2021 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2020 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2019 I | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2018 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2018 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2018 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2018 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2017 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2017 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2017 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2017 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2016 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2016 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2016 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2016 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2015 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2015 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2015 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2015 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI ...
Sales revenue by country| Turnover EUR | 2022 prognosis | 2023 prognosis | 2024 prognosis | Trend |
| Total sales | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Total exports | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI ...
Financial indicators and prognosis| Financial indicators | 2022 Prognosis | 2023 Prognosis | 2024 Prognosis |
Trend |
| TURNOVER | ...... | ...... | ...... | |
| Estonia | ...... | ...... | ...... | |
| Other countries | ...... | ...... | ...... | |
| INTEREST INCOME | ...... | ...... | ...... | |
| OTHER BUSINESS INCOME | ...... | ...... | ...... | |
| TURNOVER IN RELATED COMPANY | ...... | ...... | ...... | |
| AVERAGE MONTHLY TURNOVER | ...... | ...... | ...... | |
| Available credit (credit limit) | ...... | ...... | ...... | |
| Settlement dates | ...... | ...... | ...... | |
| RECEIVED GRANTS € | ...... | ...... | ...... | |
| TENDERS WON € | ...... | ...... | ...... | |
| ASSETS | ...... | ...... | ...... | |
| Current assets | ...... | ...... | ...... | |
| Fixed assets | ...... | ...... | ...... | |
| LIABILITIES | ...... | ...... | ...... | |
| Short-term liabilities | ...... | ...... | ...... | |
| Long-term liabilities | ...... | ...... | ...... | |
| EQUITY | ...... | ...... | ...... | |
| Share-(equity capital) | ...... | ...... | ...... | |
| Retained profits | ...... | ...... | ...... | |
| Net profit | ...... | ...... | ...... | |
| NET WORKING CAPITAL | ...... | ...... | ...... | |
| NUMBER OF EMPLOYEES | ...... | ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI ...
Financial raiting: "SATISFACTORY" (2024 prognosis)| Multipliers and income levels | 2023 prognosis | 2024 prognosis |
Trend |
| LIQUIDITY | ...... | ...... | |
| Net Working capital | ...... | ...... | |
| Short-term debt coverage ratio (X) | ...... | ...... | |
| EFFECTIVENESS | ...... | ...... | |
| Debt to assets ratio (X) | ...... | ...... | |
| Capitalisation multiplier (X) | ...... | ...... | |
| USE OF LOAN CAPITAL | ...... | ...... | |
| Turnover ratio of fixed assets (X) | ...... | ...... | |
| PROFITABILITY | ...... | ...... | |
| Sales revenues (%) | ...... | ...... | |
| Total asset revenues (%) | ...... | ...... | |
| Equity revenues (%) | ...... | ...... |
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.01.2023–31.12.2023 | 28.06.2024 | ...... |
| 2022 | 01.01.2022–31.12.2022 | 18.06.2024 | ...... |
| 2021 | 01.01.2021–31.12.2021 | 18.06.2024 | ...... |
| 2020 | 01.01.2020–31.12.2020 | 08.07.2021 | ...... |
| 2019 | 01.01.2019–31.12.2019 | 13.05.2021 | ...... |
| 2018 | 01.01.2018–31.12.2018 | 13.05.2021 | ...... |
| 2017 | 01.01.2017–31.12.2017 | 21.06.2018 | ...... |
| 2016 | 01.01.2016–31.12.2016 | 21.06.2018 | ...... |
| 2015 | 01.01.2015–31.12.2015 | 21.06.2018 | ...... |
| 2014 | 01.01.2014–31.12.2014 | 21.07.2015 | ...... |
| 2013 | 01.01.2013–31.12.2013 | 21.07.2015 | ...... |
| 2012 | 01.01.2012–31.12.2012 | 21.07.2015 | ...... |
| 2011 | 01.01.2011–31.12.2011 | 21.07.2015 | ...... |
| 2010 | 01.01.2010–31.12.2010 | 21.07.2015 | ...... |
| 2009 | 01.01.2009–31.12.2009 | 21.07.2015 | ...... |
Liabilities and debts
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral
Borderline
Problematic
Risky
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Reports and assets-liabilities overview 26.03.2025?
Annual reports:
......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Claims history?
1 month
6 months
Year
5 years
MAX
1 month
6 months
Year
5 years
MAX
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2022 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2021 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2020 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 II | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2019 I | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2018 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2017 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2016 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2015 I | ...... € | ...... € | ...... € | ...... € | ...... |
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Bailiff's enforcement proceedings as of 26.03.2025?
Bailiff's enforcement proceedings MISSING
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Regulations of the Payment Order Department as of 26.03.2025?
Regulations of the Payment Order Department MISSING
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Court orders in the register as of 26.03.2025?
Trahvihoiatusmäärus: majandusaasta aruanne esitamata
13.05.2021
Regulation number: Ä 10123456 / M5
Regulation status has entered into force: 12.05.2021
Date of enforcement of order or additional period: 13.05.2021
Regulation status: Puudused kõrvaldatud
Puuduste kõrvaldamise määrus
10.03.2021
Regulation number: Ä 10123456 / M4
Regulation status has entered into force: 15.03.2021
Date of enforcement of order or additional period: 10.03.2021
Regulation status: Puudused kõrvaldatud
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Decisions of the Consumer Disputes Committee as of 26.03.2025?
Consumer disputes MISSING
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Court hearings as of 26.03.2025?
Court hearings MISSING
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Rulings as of 26.03.2025?
Court settlemets MISSING
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Notices and announcements as of 26.03.2025?
Notice of service of a decision of the registration department of a court
19.06.2018
Kohtu registriosakonna määruse kättetoimetamise teade
Avaldamise algus: 19.06.2018
Avaldamise lõpp: 19.12.2018
Avaldamise lõpp: 19.12.2018
Tartu Maakohtu registriosakond avaldab teadaande tsiviilkohtumenetluse seadustiku (TsMS) § 317 lõike 3 alusel.
Kohus toimetab isikule, UNIMED PHARMA spol.s r.o. Eesti filiaal (registrikood: 11558952), avalikult kätte 23.05.2018 määruse nr Ä 10123456 / M2 väljavõtte:
Kohus toimetab isikule, UNIMED PHARMA spol.s r.o. Eesti filiaal (registrikood: 11558952), avalikult kätte 23.05.2018 määruse nr Ä 10123456 / M2 väljavõtte:
Avaldada väljaandes Ametlikud Teadaanded järgmise sisuga avalikult kättetoimetatava määruse Ä 10123456 / M2 väljavõte:
Anda filiaalile UNIMED PHARMA spol.s r.o. Eesti filiaal (registrikood 11558952) 2015 ja 2016. aasta majandusaasta aruande esitamiseks 60 päeva, alates määruse kättetoimetamisest.
Määruse peale ei saa esitada määruskaebust.
Dokument loetakse avalikult kättetoimetatuks 15 päeva möödumisel väljavõtte väljaandes Ametlikud Teadaanded ilmumise päevast.
Tartu Maakohtu registriosakond
Pikk 32, 44307 Rakvere
Telefon: 601 1166
E-post: registriosakond@kohus.ee
Pikk 32, 44307 Rakvere
Telefon: 601 1166
E-post: registriosakond@kohus.ee
Teadaande number 1309166
Marketing
Business network
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Beneficiaries network
UNIMED PHARMA SPOL.S R.O. EESTI FILIAAL
Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired
Sign in
To expand your connections, log in to the "Networks" environment
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
12.03.2025
Tax arrears paid
14.01.2025
Change in credit limit
Credit limit decreased (1100 EUR)
13.01.2025
Employment data update
0 employee(s) joined the organization fourth quarter of 2024, and the average salary was 3760 € per month, which is -9,4% (390 €) lower than the preceding quarter.
(The average salary for the last 4 quarters was 3835 €)
13.01.2025
The declaration of turnover
Declared taxable sales amounted to 0 € of labor taxes were paid for the fourth quarter of 2024, which is 0% (0 €) higher, than the preceding quarter.
No monitoring events found.
Failed to load monitoring events.